News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzymotec To Present New Findings Regarding Positive Effects Of INFAT® On Chinese Babies Stool And Behavior


6/6/2014 9:02:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIGDAL HA'EMEQ, Israel, June 5, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that results of its clinical trial on INFATĀ® (structured fat ingredient for infant nutrition, marketed by Advanced Lipids, a joint venture of AAK and Enzymotec) will be presented at the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Conference on June 9-12, 2014 in Jerusalem, Israel (to read the full scientific abstract go to: http://journals.lww.com/jpgn/Documents/ESPGHAN%202014%20Abstracts%20-%20Complete%20abstracts.pdf Page: 432).

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
Enzymotec
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES